ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,396,943, issued on Aug. 26, was assigned to CSL Behring AG (Bern, Switzerland).
"Hemopexin formulations" was invented by Thomas Gentinetta (Bern, Switzerland), Nathan Brinkman (Herscher, Ill.), David Boerema (Bourbonnais, Ill.), Bo An (Bourbonnais, Ill.) and Kyle Miner (Bourbonnais, Ill.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates generally to a stable liquid formulation of purified hemopexin comprising: (a) a hemopexin content of at least 50 mg/mL; (b) at least 15 mM phosphate buffer; (c) a pH from 5.8 to 8; and (d) at least 50 mM sodium chloride; and uses thereof."
The patent was filed on Aug. 8, 2018, under Applicati...